Weiwei Feng

13PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Obstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 28, 2026
Identification of COX7B, GLRX5, and OR52H1 as Vascular Endothelial Injury-associated Biomarkers in Gestational Diabetes Mellitus.

|Jun 29, 2026
BRD4-mediated histone H4K12 lactylation drives ovarian cancer progression by activating the Ube2v1-DDX3X ubiquitination axis.

|May 26, 2026
PiggyBac-engineered membrane-bound IL-7 TILs combined with anti-PD-1 antibody demonstrates efficacy in recurrent ovarian cancer: a first-in-human phase 1 trial.

|Dec 26, 2025
Modification-Driven Nanocarriers: Ovarian Cancer Cell Membrane- Camouflaged Indoximod/Doxorubicin Co-Delivery Systems for Synergistic Immunochemotherapy.

Yiyin Ruan, Huijie Han, Xin Guan

|Dec 03, 2025
Red blood cell-hitchhiking fluorescent probe to promote intraoperative diagnosis of human ovarian tumor.

Yijing Lin, Ke Li, Yue Ding

|Jan 12, 2024
Can surgery boost the survival benefit of chemoradiotherapy in T1b1-T2a1 stage cervical cancer with lymph node metastasis? A population-based study.

Yiwei Wang, You Lyu, Xiaoxia Che

Pageof 3

Frequent Collaborators

2 joint publications

Xin He

2 joint publications

Keqin Hua

2 joint publications

Yudong Wang

1 joint publications

Hui Chen